R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
Autorzy :
Conboy CB; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA. Vélez-Reyes GL; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA. Rathe SK; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA. Abrahante JE; University of Minnesota Informatics Institute, Minneapolis, Minnesota, USA. Temiz NA; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA. Burns MB; Biochemistry, Molecular Biology and Biophysics Department, University of Minnesota, Minneapolis, Minnesota, USA.; Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA. Harris RS; Biochemistry, Molecular Biology and Biophysics Department, University of Minnesota, Minneapolis, Minnesota, USA.; Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota, USA. StarrTK; Department of Obstetrics, Gynecology and Women's Health and University of Minnesota, Minneapolis, Minnesota, USA. Largaespada DA; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło :
DNA and cell biology [DNA Cell Biol] 2021 Jan; Vol. 40 (1), pp. 70-79. Date of Electronic Publication: 2020 Dec 15.
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Autorzy :
Law EK; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Levin-Klein R; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Jarvis MC; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Kim H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Argyris PP; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN.; Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, MN. Carpenter MA; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Starrett GJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN.; Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD. Temiz NA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Health Informatics, University of Minnesota, Minneapolis, MN. Larson LK; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Durfee C; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN. Burns MB; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN.; Department of Biology, Loyola University, Chicago, IL. Vogel RI; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN. Stavrou S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL. Aguilera AN; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL. Wagner S; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Department of Pediatrics, University of Minnesota, Minneapolis, MN. Largaespada DA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Department of Pediatrics, University of Minnesota, Minneapolis, MN. StarrTK; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN. Ross SR; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL. Harris RS; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN.
Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
Autorzy :
Tiwari A; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Electronic address: . Tashiro K; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Dixit A; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota. Soni A; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Vogel K; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Hall B; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Shafqat I; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Slaughter J; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Param N; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Le A; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Saunders E; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Paithane U; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Garcia G; Histology Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Campos AR; Proteomics Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Zettervall J; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota. Carlson M; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota. StarrTK; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Marahrens Y; Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota. Deshpande AJ; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Commisso C; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Provenzano PP; Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota. Bagchi A; Tumor Initiation and Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. Electronic address: .
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2020 Nov; Vol. 159 (5), pp. 1882-1897.e5. Date of Electronic Publication: 2020 Aug 05.
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Autorzy :
Geistlinger L; Graduate School of Public Health and Health Policy, City University of New York, New York, New York.; Institute for Implementation Science and Population Health, City University of New York, New York, New York. Oh S; Graduate School of Public Health and Health Policy, City University of New York, New York, New York.; Institute for Implementation Science and Population Health, City University of New York, New York, New York. Ramos M; Graduate School of Public Health and Health Policy, City University of New York, New York, New York.; Institute for Implementation Science and Population Health, City University of New York, New York, New York.; Roswell Park Comprehensive Cancer Institute, Buffalo, New York. Schiffer L; Graduate School of Public Health and Health Policy, City University of New York, New York, New York.; Institute for Implementation Science and Population Health, City University of New York, New York, New York. LaRue RS; Minnesota Supercomputing Institute, Minneapolis, Minnesota.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Henzler CM; Minnesota Supercomputing Institute, Minneapolis, Minnesota.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Munro SA; Minnesota Supercomputing Institute, Minneapolis, Minnesota.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Daughters C; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. Nelson AC; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota. Winterhoff BJ; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota.; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Chang Z; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Talukdar S; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Shetty M; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Mullany SA; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Morgan M; Roswell Park Comprehensive Cancer Institute, Buffalo, New York. Parmigiani G; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Birrer MJ; The Winthrop P Rockefeller Cancer Institute, University of Arkansas Medical Sciences, Little Rock, Arkansas. Qin LX; Memorial Sloan Kettering Cancer Center, New York, New York. Riester M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. StarrTK; University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota.; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Waldron L; Graduate School of Public Health and Health Policy, City University of New York, New York, New York. .; Institute for Implementation Science and Population Health, City University of New York, New York, New York.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Oct 15; Vol. 80 (20), pp. 4335-4345. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer.
Autorzy :
Layek B; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA. Shetty M; Department of Obstetrics, Gynecology and Women's Health (OBGYN), University of Minnesota, Minneapolis, MN 55455, USA. Nethi SK; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.; Fels Institute for Cancer Research & Molecular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Sehgal D; School of Pharmacy, Temple University, Philadelphia, PA 19140, USA. StarrTK; Department of Obstetrics, Gynecology and Women's Health (OBGYN), University of Minnesota, Minneapolis, MN 55455, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Prabha S; Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.; Fels Institute for Cancer Research & Molecular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Apr 14; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 14.
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Autorzy :
Pomeroy EJ; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Hunzeker JT; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Kluesner MG; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Lahr WS; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Smeester BA; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Crosby MR; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Lonetree CL; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Yamamoto K; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. Bendzick L; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. Miller JS; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. Geller MA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN 55455, USA. Felices M; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. Webber BR; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. StarrTK; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. Moriarity BS; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: .
R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent Manner.
Autorzy :
Conboy CB; Masonic Cancer Center University of Minnesota Minneapolis MN. Vélez-Reyes GL; Masonic Cancer Center University of Minnesota Minneapolis MN. Tschida BR; Masonic Cancer Center University of Minnesota Minneapolis MN. Hu H; Masonic Cancer Center University of Minnesota Minneapolis MN. Kaufmann G; Masonic Cancer Center University of Minnesota Minneapolis MN. Koes N; Masonic Cancer Center University of Minnesota Minneapolis MN. Keller B; Masonic Cancer Center University of Minnesota Minneapolis MN. Alsinet C; Liver Cancer Translational Research Laboratory Liver Unit, L'Institut d'Investigacions Biomèdiques August Pi i Sunyer-Hospital Clinic of Barcelona University of Barcelona Barcelona Spain. Cornellà H; Liver Cancer Translational Research Laboratory Liver Unit, L'Institut d'Investigacions Biomèdiques August Pi i Sunyer-Hospital Clinic of Barcelona University of Barcelona Barcelona Spain. Pinyol R; Liver Cancer Translational Research Laboratory Liver Unit, L'Institut d'Investigacions Biomèdiques August Pi i Sunyer-Hospital Clinic of Barcelona University of Barcelona Barcelona Spain. Abrahante JE; University of Minnesota Informatics Institute Minneapolis MN. Temiz NA; Masonic Cancer Center University of Minnesota Minneapolis MN. Linden MA; Comparative Pathology Shared Resource University of Minnesota St. Paul MN.; Department of Medicine Division of Hematology, Oncology, and Transplantation University of Minnesota Minneapolis MN. Amin K; Comparative Pathology Shared Resource University of Minnesota St. Paul MN.; Department of Medicine Division of Hematology, Oncology, and Transplantation University of Minnesota Minneapolis MN. Kuka TP; Masonic Cancer Center University of Minnesota Minneapolis MN. Keng VW; Masonic Cancer Center University of Minnesota Minneapolis MN.; Department of Applied Biology and Chemical Technology Hong Kong Polytechnic University Kowloon Hong Kong. Llovet JM; Liver Cancer Translational Research Laboratory Liver Unit, L'Institut d'Investigacions Biomèdiques August Pi i Sunyer-Hospital Clinic of Barcelona University of Barcelona Barcelona Spain.; Mount Sinai Liver Cancer Program Division of Liver Diseases Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York NY.; Catalan Institution for Research and Advanced Studies Barcelona Spain. StarrTK; Department of Obstetrics, Gynecology, and Women's Health University of Minnesota Minneapolis MN. Largaespada DA; Masonic Cancer Center University of Minnesota Minneapolis MN.; Department of Pediatrics University of Minnesota Minneapolis MN.
Pokaż więcej
Źródło :
Hepatology communications [Hepatol Commun] 2019 Sep 03; Vol. 3 (11), pp. 1496-1509. Date of Electronic Publication: 2019 Sep 03 (Print Publication: 2019).
De novo prediction of cell-type complexity in single-cell RNA-seq and tumor microenvironments.
Autorzy :
Woo J; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Winterhoff BJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA. StarrTK; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA. Aliferis C; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA. Wang J; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA .; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło :
Life science alliance [Life Sci Alliance] 2019 Jul 02; Vol. 2 (4). Date of Electronic Publication: 2019 Jul 02 (Print Publication: 2019).
Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells.
Autorzy :
Desir S; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. .; Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, 55455 MN, USA. . Wong P; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. .; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN 55455, USA. . Turbyville T; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. . Chen; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. . Shetty M; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA. . Clark C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA. . Zhai E; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. . Romin Y; Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. . Manova-Todorova K; Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. . StarrTK; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN 55455, USA. . Nissley DV; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. . Steer CJ; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN 55455, USA. . Subramanian S; Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA. . Lou E; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. .
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2019 Jun 26; Vol. 11 (7). Date of Electronic Publication: 2019 Jun 26.
Biological Insights into Chemotherapy Resistance in Ovarian Cancer.
Autorzy :
Glasgow MA; Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. . Argenta P; Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. . Abrahante JE; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. . Shetty M; Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. . Talukdar S; Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. . Croonquist PA; Department of Biology, Anoka Ramsey Community College, Coon Rapids, MN 55455, USA. . Khalifa MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. . StarrTK; Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN 55455, USA. .
Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.
Autorzy :
Skubitz APN; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. .; Ovarian Cancer Early Detection Program, University of Minnesota, Minneapolis, Minnesota.; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Boylan KLM; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Ovarian Cancer Early Detection Program, University of Minnesota, Minneapolis, Minnesota. Geschwind K; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Ovarian Cancer Early Detection Program, University of Minnesota, Minneapolis, Minnesota. Cao Q; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. StarrTK; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota. Geller MA; Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Celestino J; University of Texas, MD Anderson Cancer Center, Houston, Texas. Bast RC Jr; University of Texas, MD Anderson Cancer Center, Houston, Texas. Lu KH; University of Texas, MD Anderson Cancer Center, Houston, Texas. Koopmeiners JS; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
Meta-analytic framework for modeling genetic coexpression dynamics.
Autorzy :
Kinzy TG; Case Western Reserve University, Cleveland, USA. StarrTK; University of Minnesota, Minneapolis, USA. Tseng GC; University of Pittsburgh, Pittsburgh, USA. Ho YY; Department of Statistics, University of South Carolina, Columbia, SC29209,USA.
Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma.
Autorzy :
Rahrmann EP; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota. .; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Wolf NK; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota. Otto GM; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Heltemes-Harris L; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Lab Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Department of Laboratory Medicine and Pathology, Division of Hematopathology, University of Minnesota, Minneapolis, Minnesota. Ramsey LB; Department of Laboratory Medicine and Pathology, Division of Hematopathology, University of Minnesota, Minneapolis, Minnesota. Shu J; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. LaRue RS; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Linden MA; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Center for Immunology, University of Minnesota, Minneapolis, Minnesota. Rathe SK; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. StarrTK; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Ob-Gyn and Women's Health, University of Minnesota, Minneapolis, Minnesota. Farrar MA; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Lab Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.; Department of Laboratory Medicine and Pathology, Division of Hematopathology, University of Minnesota, Minneapolis, Minnesota. Moriarity BS; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.; Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota. Largaespada DA; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.; Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota.
Pokaż więcej
Źródło :
Molecular cancer research : MCR [Mol Cancer Res] 2019 Feb; Vol. 17 (2), pp. 567-582. Date of Electronic Publication: 2018 Oct 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.
Autorzy :
Winterhoff B; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health.; Masonic Cancer Center. Talukdar S; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health. Chang Z; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health. Wang J; Institute of Health Informatics, University of Minnesota, Minneapolis, Minnesota, USA. StarrTK; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women's Health.; Masonic Cancer Center.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
